High-dose oral supplementation of antioxidants and glutamine improves the antioxidant status in patients with Crohn's disease: A pilot study

e-SPEN

Volumn 3, Issue 5, 2008, Pages

  Roggenbuck, Cornelia ^a   Lammert, Frank ^b   Berthold, Heiner K ^b   Giese, Thomas ^c   Stallmach, Andreas ^d   Stehle, Peter ^a   Ellinger, Sabine ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Antioxidants; Crohn's disease; Glutamine; intervention; Mucosal inflammation; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BIOLOGICAL MARKER; GLUTAMINE; GLUTATHIONE; INTERLEUKIN 8; MESSENGER RNA; MYELOID RELATED PROTEIN 14; PEROXIDE; PLACEBO; PROTEIN DERIVATIVE; SELENIUM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; DRUG MEGADOSE; ENTERITIS; FEMALE; HUMAN; INTESTINE MUCOSA; LEUKOCYTE; MALE; MUCOSA INFLAMMATION; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

EID: 52049116301     PISSN: 17514991     EISSN: 17514991     Source Type: Journal    
DOI: 10.1016/j.eclnm.2008.06.012     Document Type: Article

References (41)

1. Dryden Jr. G.W., Deaciuc I., Arteel G., and McClain C.J. Clinical implications of oxidative stress and antioxidant therapy. Curr Gastroenterol Rep 7 (2005) 308-316
2. Grimble R.F. Nutritional antioxidants and the modulation of inflammation: theory and practice. New Horiz 2 (1994) 175-185
3. McKenzie S.J., Baker M.S., Buffinton G.D., and Doe W.F. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 98 (1996) 136-141
4. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E., et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41 (1996) 2078-2086
5. Levy E., Rizwan Y., Thibault L., Lepage G., Brunet S., Bouthillier L., et al. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr 71 (2000) 807-815
6. Reimund J.M., Hirth C., Koehl C., Baumann R., and Duclos B. Antioxidant and immune status in active Crohn's disease. A possible relationship. Clin Nutr 19 (2000) 43-48
7. D'Odorico A., Bortolan S., Cardin R., D'Inca R., Martines D., Ferronato A., and Sturniolo G.C. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36 (2001) 1289-1294
8. Wendland B.E., Aghdassi E., Tam C., Carrrier J., Steinhart A.H., Wolman S.L., et al. Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am J Clin Nutr 74 (2001) 259-264
9. Sampietro G.M., Cristaldi M., Cervato G., Maconi G., Danelli P., Cervellione R., et al. Oxidative stress, vitamin A and vitamin E behaviour in patients submitted to conservative surgery for complicated Crohn's disease. Dig Liver Dis 34 (2002) 696-701
10. Fernandez-Banares F., Abad-Lacruz A., Xiol X., Gine J.J., Dolz C., Cabre E., et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 84 (1989) 744-748
11. Kuroki F., Iida M., Tominaga M., Matsumoto T., Hirakawa K., Sugiyama S., et al. Multiple vitamin status in Crohn's disease. Correlation with disease activity. Dig Dis Sci 38 (1993) 1614-1618
12. Bousvaros A., Zurakowski D., Duggan C., Law T., Rifai N., Goldberg N.E., et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr 26 (1998) 129-135
13. Geerling B.J., van Houwelingen A.C., Badart-Smook A., Stockbrugger R.W., and Brummer R.J. The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn disease and controls. Scand J Gastroenterol 34 (1999) 1108-1116
14. Buffinton G.D., and Doe W.F. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic Biol Med 19 (1995) 911-918
15. Miralles-Barrachina O., Savoye G., Belmonte-Zalar L., Hochain P., Ducrotte P., Hecketsweiler B., et al. P. Low levels of glutathione in endoscopic biopsies of patients with Crohn's colitis: the role of malnutrition. Clin Nutr 18 (1999) 313-317
16. Aghdassi E., Wendland B.E., Steinhart A.H., Wolman S.L., Jeejeebhoy K., and Allard J.P. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial. Am J Gastroenterol 98 (2003) 348-353
17. Basivireddy J., Jacob M., and Balasubramanian K.A. Oral glutamine attenuates indomethacin-induced small intestinal damage. Clin Sci (Lond) 107 (2004) 281-289
18. Coeffier M., Marion R., Leplingard A., Lerebours E., Ducrotte P., and Dechelotte P. Glutamine decreases interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins e(2) production by human gut in-vitro. Cytokine 18 (2002) 92-97
19. Coeffier M., Miralles-Barrachina O., Le Pessot F., Lalaude O., Daveau M., Lavoinne A., et al. Influence of glutamine on cytokine production by human gut in vitro. Cytokine 13 (2001) 148-154
20. Detsky A.S., McLaughlin J.R., Baker J.P., Johnston N., Whittaker S., Mendelson R.A., et al. What is subjective global assessment of nutritional status?. J Parenter Enteral Nutr 11 (1987) 8-13
21. Erhardt J.G., Heinrich F., and Biesalski H.K. Determination of retinol, antioxidant vitamins and homocysteine in skin puncture blood. Int J Vitam Nutr Res 69 (1999) 309-314
22. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., and Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 84 (1993) 407-412
23. Kuhn K.S., Krasselt A.I., and Furst P. Glutathione and glutathione metabolites in small tissue samples and mucosal biopsies. Clin Chem 46 (2000) 1003-1005
24. Furst P., Pollack L., Graser T.A., Godel H., and Stehle P. Appraisal of four pre-column derivatization methods for the high-performance liquid chromatographic determination of free amino acids in biological materials. J Chromatogr 499 (1990) 557-569
25. Arendt B.M., Ellinger S., Kekic K., Geus L., Fimmers R., Spengler U., et al. Single and repeated moderate consumption of native or dealcoholized red wine show different effects on antioxidant parameters in blood and DNA strand breaks in peripheral leukocytes in healthy volunteers: a randomized controlled trial (ISRCTN68505294). Nutr J 4 (2005) 33
26. Stallmach A., Giese T., Schmidt C., Ludwig B., Mueller-Molaian I., and Meuer S.C. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int J Colorectal Dis 19 (2004) 308-315
27. Janke K.H., Klump B., Steder-Neukamm U., Hoffmann J., and Hauser W. [Validation of the German Version of the Inflammatory Bowel Disease Questionnaire (Competence Network IBD, IBDQ-D)]. Psychother Psychosom Med Psychol 56 (2006) 291-298
28. Trebble T.M., Arden N.K., Wootton S.A., Calder P.C., Mullee M.A., Fine D.R., et al. Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am J Clin Nutr 80 (2004) 1137-1144
29. Geerling B.J., Badart-Smook A., van Deursen C., van Houwelingen A.C., Russel M.G., Stockbrugger R.W., et al. Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis 6 (2000) 77-84
30. Novak F., Heyland D.K., Avenell A., Drover J.W., and Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 30 (2002) 2022-2029
31. German Nutrition Society (DGE) ANSÖ, Swiss Society for Nutrition Research (SGE), Swiss Nutrition Association (AVE), editors. Reference Values for Nutrient Intake. Frankfurt/Main, Germany, Umschau Braus; 2002.
32. Mulder T.P., van der Sluys Veer A., Verspaget H.W., Griffioen G., Pena A.S., Janssens A.R., et al. Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol 9 (1994) 472-477
33. Sturniolo G.C., Di Leo V., Ferronato A., D'Odorico A., and D'Inca R. Zinc supplementation tightens "leaky gut" in Crohn's disease. Inflamm Bowel Dis 7 (2001) 94-98
34. Genser D., Kang M.H., Vogelsang H., and Elmadfa I. Status of lipid soluble antioxidants and TRAP in patients with Crohn's disease and healthy controls. Eur J Clin Nutr 53 (1999) 675-679
35. Sido B., Seel C., Hochlehnert A., Breitkreutz R., and Droge W. Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation?. Dig Dis Sci 51 (2006) 2170-2179
36. Kruidenier L., Kuiper I., Van Duijn W., Mieremet-Ooms M.A., van Hogezand R.A., Lamers C.B., et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 201 (2003) 17-27
37. Miller A.L. Therapeutic considerations of L-glutamine: a review of the literature. Altern Med Rev 4 (1999) 239-248
38. Den Hond E., Hiele M., Peeters M., Ghoos Y., and Rutgeerts P. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease. J Parenter Enteral Nutr 23 (1999) 7-11
39. Thomson C.D. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 58 (2004) 391-402
40. Seidner D.L., Lashner B.A., Brzezinski A., Banks P.L., Goldblum J., Fiocchi C., et al. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 3 (2005) 358-369
41. Koutroubakis I.E., Malliaraki N., Dimoulios P.D., Karmiris K., Castanas E., and Kouroumalis E.A. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci 49 (2004) 1433-1437